Europes most advanced Digital Pharmacy

  • Best in class logistics in europe
  • Fully automated warehouse
  • Highest delivery quality
  • Digital marketing excellence
  • One of the fastest growing inline pharmacies
  • eRx as a strategic cornerstone for Apologistics
  • Extreme fairly priced products
  • Continuously developing new markets and improving our business
  • Sustainability is a key company goal for Apologistics
  • Goal: to become CO2 neutral
  • Electric and hybrid company cars
  • LEDs in the entire facility
  • Solar-Panels in preparation
  • State of the art trash sorting and handling
  • Bio-degradable packaging / filling material
Dirk Wappler
Dirk Wappler
CEO & Co-Founder
Nico Grunert
Nico Grunert
CFO
Daniel Bauer
Daniel Bauer
Head of HR
Christian Klossek
Christian Klossek
Head of IT
Carsten Werner
Carsten Werner
Head of Production
Christian Richter
Christian Richter
Head of Marketing
Robert Kudrass
Robert Kudrass
Head of regulatory affairs
Daniel Mühl
Daniel Mühl
COO (Duiven)
Anke Kirchner
Anke Kirchner
Head of customer service

Pharmaceutical market overview Germany

  • "Germany: highly attractive and rapidly changing healthcare market"
  • "eRx game changer for the industry" - We want to play a dominant role in this.
  • "Huge potential, just a small portion of Rx market shifted to online" - € 5 B shift from offline to online exprected
  • "The e-prescription will accelerate stationary pharmacy consolidation and ensure high online Rx growth."
  • "The issuing of follow-up prescriptions by pharmacists is highly advantage for online pharmacies"
  • "Half of sonsumers can imagine redeeming an e-prescription online"
  • "Manufacturers have the most positive attitude towards the introdution of the e-prescription"
  • "Clear winners of e-prescriptions will be online pharmacies"
  • Source: Dr.Kaske, eRx Study 2019
    Dr.Kaske specialized as a full-service marketing ogency for manufacturers, market research and pharmacies

Führende Online-Apotheken in Deutschland 2020Führende Online-Apothkenin DeutschlandUmsätze12020(in Millionen Euro)~ Marktanteil 20201Zur Rose(DocMorris,Apotal,Medpex)1.023Millionen Euro42%2Shop Apotheke600Millionen Euro25%3Apologistics(apo-discounter)200Millionen Euro8%4medikamente-per-klick150Millionen Euro6%5eurapon66Millionen Euro3%6APONEO58Millionen Euro2%7myCARE45Millionen Euro2%CHC = Consumer Gesundheit – nicht apothekenpflichtige Produkte wie Vitamine, Na-rungsergänzung, Diätprodukte und andere Gesundheitsprodukte OTC = Over-the-counter - apothekenpflichtige Produkte; Rx = Verschreibungspflichtige Medikamente ohne Kranke-haus1. Umsatz in Deutschland; Umsätze teilweise geschätztSource: Kearney analysis, IQVIA, Euromonitor, Jefferies, Barclays, Kepler, Deutsche Bank, BCC Research, Company Reports, Orbis, Statista
Der Online-Apothekenmarkt in Deutschland wird sich bis 2025 verfünffachen (EUR Milliarden)72.4%13.0%11.9%CAGR2020-20250,60,93,89,00,91,01,31,70,91,01,31,62,92,412,36,438%Online CHC (excl. OTC)Online OTCOnline RxEinführung E-Rezept ab Januar 2022

Our Investors

THI Investments Logo

THI Investments is a single family office founded in January 2016 after divesting an 80 year-old family business. Our goal is to invest in a diversified portfolio of financial and company assets and grow them over the long term. We are entrepreneurs, industrialists and investors. Our companies are designed to adapt to and thrive on rapid global changes, such as digitisation, demographics, urbanisation and resource sustainability. Success is defined not only by the returns and growth we achieve – but also by how we achieve them.

THI Investments is values-driven because that’s the way its owners, management and team want it to be. Our partners’, co-investors’ and team members’ success is part of how we measure our performance. We manage risk through diversification, flexibility, execution excellence, partnership and a positive and optimistic outlook. We have the patience and the vision to realise success over the long term.

Our business partners

A.T. Kearney Holdings Limited Logo
Orrick, Herrington & Sutcliffe LLP Logo
CMS Legal Services EEIG Logo
Ernst & Young GmbH Logo
amazon Logo
Gleiss Lutz Logo
google Logo
facebook Logo
DHL Logo
bookmark

Press Release

Dr. Oliver Scheel new CEO at Apologistics GmbH

Leipzig, April 2021

On 1 April 2021, Dr Oliver Scheel took over as CEO of the ApologisticsGroup (apologistics.com) from founder and long-time CEO Michael Fritsch, who built up the company and led it to its current success. With overall responsibility, Dr Scheel will lead the further growth of the ApologisticsGroup and further expand its position as the largest privately owned "pharmacy for all" in the German healthcare market. Michael Fritsch will remain on the company's advisory board and will continue to support the successful growth of the company with his extensive expertise in the pharmacy market as an advisor and shareholder.
...read more

Download PDF Press release

Interview with Handelsblatt

Düsseldorf, Frankfurt, 30 November 2020

Deutsche Digitalapotheke nimmt es mit den ausländischen Branchenprimi auf
Als Betreiber der drittgrößten Versandapotheke in Deutschland hat Michael Fritsch ehrgeizige Ziele – und fürchtet weder die direkte Konkurrenz noch Amazon.

read complete interview on www.handelsblatt.com

Apologistics announces partnership with THI Investments

Leipzig, 27 March 2018

Apologistics GmbH, a Leipzig-based logistics service provider for online pharmacies, announced a strategic partnership with THI Investments GmbH:

Founded in 2004, Apologistics is located close to DHL’s European logistics hub in Leipzig and operates an industry-leading, fully-automated logistics service centre for OTC (non-prescription) drugs and beauty & care products which can handle up to 8 million parcels per year.
...read more

Download PDF Press release